The NAFLD patients had a higher age, ratio of males to females, BMI, SBP, DBP, WC, HC values and serum levels of ALT, AST, fasting blood-glucose (FBG), low density lipoprotein cholesterin (LDL-c), triglyceride (TG) and total cholesterol (TC) than the non-NAFLD patients (all P < 0.05). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.